myriamed offers a two-tiered phenotypic screening approach. This includes a primary screen in a proprietary 48-cell format followed by result verification using classical organ bath measurements under isometric conditions. Endpoints include force, beating rate and rhythm, contraction kinetics and many more. Please contact us for further details. The myrScreen stategy is adapted according to the specific needs of our customers.
myrScreen-Cardio is a human 48-well platform that allows analyses of function and dysfunction as well as regeneration and degeneration in engineered human hearts.
myrScreen-Skeletal allows the simultaneously analyses of function and dysfunction as well as regeneration and degeneration in 48 engineered human skeletal muscle models.